GRI BIO, INC. (GRI) Current Ratio
- Current ratio · latest quarter: Value 10.30×; Formula and calculation Current assets / current liabilities..
Current ratio
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Current ratio · latest quarter | 10.30× | Current assets / current liabilities. $11.33M ÷ $1.10M ≈ 10.30× |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Current assets | 11.33M USD | Assets, Current |
| Current obligations | 1.10M USD | Liabilities, Current |
| Cash and equivalents | 10.95M USD | Cash and Cash Equivalents, at Carrying Value |
| Short-term securities | (m) | Debt Securities, Available-for-sale, Current |
| Customer receivables | (m) | |
| Inventory | (m) | |
| Payables | 526.00K USD | Accounts Payable, Current |
| Borrowing debt due within one year | (m) |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Current assets (USD) | Current obligations (USD) | Cash and equivalents (USD) | Short-term securities (USD) | Customer receivables (USD) | Inventory (USD) | Payables (USD) | Borrowing debt due within one year (USD) | Current ratio |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $11.33M | $1.10M | $10.95M | (m) | (m) | (m) | $526.00K | (m) | 10.30× |
| 2026-03-31 | $11.28M | $794.00K | $11.05M | (m) | (m) | (m) | $303.00K | (m) | 14.21× |
| 2025-12-31 | $8.59M | $2.64M | $8.23M | (m) | (m) | (m) | $1.84M | (m) | 3.25× |
| 2025-09-30 | $4.70M | $2.76M | $4.05M | (m) | (m) | (m) | $1.32M | (m) | 1.70× |
| 2025-06-30 | $5.58M | $2.31M | $5.12M | (m) | (m) | (m) | $1.30M | (m) | 2.41× |
| 2025-03-31 | $3.93M | $2.78M | $3.28M | (m) | (m) | (m) | $1.36M | (m) | 1.41× |
| 2024-12-31 | $5.62M | $1.64M | $5.03M | (m) | (m) | (m) | $897.00K | (m) | 3.43× |
| 2024-09-30 | $5.32M | $1.72M | $4.75M | (m) | (m) | (m) | $1.14M | (m) | 3.10× |
| 2024-06-30 | $6.88M | $2.22M | $6.35M | (m) | (m) | (m) | $1.24M | (m) | 3.11× |
| 2024-03-31 | $4.43M | $1.68M | $4.09M | (m) | (m) | (m) | $637.00K | (m) | 2.64× |
| 2023-12-31 | $2.93M | $2.70M | $1.81M | (m) | (m) | (m) | $1.41M | (m) | 1.09× |
| 2023-09-30 | $4.37M | $2.18M | $3.49M | (m) | (m) | (m) | $988.00K | (m) | 2.01× |
| 2023-06-30 | $5.59M | $1.60M | $4.80M | (m) | (m) | (m) | $307.00K | (m) | 3.49× |
| 2022-12-31 | $312.00K | $1.99M | $9.00K | (m) | (m) | (m) | $1.29M | (m) | 0.16× |
| 2022-09-30 | $5.57M | $2.11M | $4.73M | $419.00K | (m) | (m) | $1.19M | (m) | 2.64× |
| 2022-06-30 | $7.84M | $4.32M | $5.22M | $1.75M | (m) | (m) | $1.81M | (m) | 1.81× |
| 2022-03-31 | $5.76M | $2.54M | $2.54M | $2.63M | (m) | (m) | $1.23M | (m) | 2.27× |
| 2021-12-31 | $8.13M | $2.44M | $3.70M | $3.81M | (m) | (m) | $918.00K | (m) | 3.32× |
| 2021-09-30 | $9.92M | $1.31M | $5.88M | $3.25M | (m) | (m) | $488.00K | (m) | 7.55× |
| 2021-06-30 | $11.40M | $1.67M | $10.46M | (m) | (m) | (m) | $886.00K | (m) | 6.82× |
| 2021-03-31 | $14.34M | $2.43M | $12.98M | (m) | (m) | (m) | $1.35M | (m) | 5.91× |
| 2020-12-31 | $674.00K | $2.23M | $109.00K | $0.00 | (m) | (m) | $1.23M | (m) | 0.30× |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.